Immunocore

NASDAQ: IMCR · Real-Time Price · USD
32.94
-0.12 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
32.88
-0.17%
After-hours: Aug 15, 2025, 04:10 PM EDT

Immunocore Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
310.2M 249.43M 143.74M 26.52M
Cost of Revenue
2.73M 1.04M 454K 73.23M
Gross Profit
307.47M 248.39M 143.28M -46.71M
Operating Income
-70.46M -59.65M -39.61M -135.16M
Interest Income
25.62M 17.99M 3.76M 65K
Pretax Income
-52.94M -60.89M -44.15M -140.93M
Net Income
-51.09M -55.29M -41.22M -131.52M
Selling & General & Admin
155.78M 144.5M 93.72M 88.4M
Research & Development
222.15M 163.54M 89.17M 73.23M
Other Expenses
n/a n/a -3K 57K
Operating Expenses
377.93M 308.04M 182.89M 161.68M
Interest Expense
18.84M 5.15M 5.41M 5.57M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
380.66M 309.08M 183.34M 161.68M
Income Tax Expense
-1.85M -5.6M -2.92M -9.4M
Shares Outstanding (Basic)
49.99M 48.89M 45.71M 42.49M
Shares Outstanding (Diluted)
49.99M 48.89M 45.71M 43.86M
EPS (Basic)
-1.02 -1.13 -0.9 -3.1
EPS (Diluted)
-1.02 -1.13 -0.9 -3
EBITDA
-70.46M -51.65M -38.35M -166.72M
EBIT
-71.78M -55.74M -35.47M -174.31M
Depreciation & Amortization
n/a 4.09M 5.33M 7.59M